1. CEA TCB: A novel head-to-tail 2:1 T cell bispecific antibody for treatment of CEA-positive solid tumors. (2nd August 2016) Authors: Bacac, Marina; Klein, Christian; Umana, Pablo Journal: Oncoimmunology Issue: Volume 5:Number 8(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗